{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:24:28Z","timestamp":1770506668246,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s10552-006-0037-3","type":"journal-article","created":{"date-parts":[[2006,7,14]],"date-time":"2006-07-14T04:49:15Z","timestamp":1152852555000},"page":"971-981","source":"Crossref","is-referenced-by-count":50,"title":["Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States)"],"prefix":"10.1007","volume":"17","author":[{"given":"Jihyoun","family":"Jeon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Georg","family":"Luebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh H.","family":"Moolgavkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","volume":"92","author":"E Bollschweiler","year":"2001","unstructured":"Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549\u2013555","journal-title":"Cancer"},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ije\/29.4.645","volume":"29","author":"AA Botterweck","year":"2000","unstructured":"Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645\u2013654","journal-title":"Int J Epidemiol"},{"key":"37_CR3","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","volume":"83","author":"SS Devesa","year":"1998","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049\u20132053","journal-title":"Cancer"},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.50.3.368","volume":"50","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50:368\u2013372","journal-title":"Gut"},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1572-0241.2003.07454.x","volume":"98","author":"MA Eloubeidi","year":"2003","unstructured":"Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973\u20131997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98:1627\u20131633","journal-title":"Am J Gastroenterol"},{"key":"37_CR6","first-page":"225","volume":"4","author":"AM Nguyen","year":"2003","unstructured":"Nguyen AM, Luke CG, Roder D (2003) Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia. Asian Pac J Cancer Prev 4:225\u2013231","journal-title":"Asian Pac J Cancer Prev"},{"key":"37_CR7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ijc.10427","volume":"99","author":"AP Vizcaino","year":"2002","unstructured":"Vizcaino AP, Moreno V, Lambert R, Parkin DM (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973\u20131995. Int J Cancer 99:860\u2013868","journal-title":"Int J Cancer"},{"key":"37_CR8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/003655202762671215","volume":"37","author":"M Younes","year":"2002","unstructured":"Younes M, Henson DE, Ertan A, Miller CC (2002) Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 37:1359\u20131365","journal-title":"Scand J Gastroenterol"},{"key":"37_CR9","doi-asserted-by":"crossref","unstructured":"Vaughan TL (2002) Esophagus. In: Franco EL, Rohan TE (eds) Cancer precursors. Springer-Verlag New York, Inc., pp 69\u2013116","DOI":"10.1007\/0-387-21605-7_8"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4065\/76.1.94","volume":"76","author":"AJ Cameron","year":"2001","unstructured":"Cameron AJ (2001) The history of Barrett esophagus. Mayo Clin Proc 76:94\u201396","journal-title":"Mayo Clin Proc"},{"key":"37_CR11","first-page":"369","volume":"6","author":"R Kim","year":"1997","unstructured":"Kim R, Weissfeld JL, Reynolds JC, Kuller LH (1997) Etiology of Barrett\u2019s metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 6:369\u2013377","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00268-003-7053-1","volume":"27","author":"S Ramel","year":"2003","unstructured":"Ramel S (2003) Barrett\u2019s esophagus:model of neoplastic progression. World J Surg 27:1009\u20131013","journal-title":"World J Surg"},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0889-8553(21)00590-2","volume":"20","author":"BJ Reid","year":"1991","unstructured":"Reid BJ (1991) Barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am 20:817\u2013834","journal-title":"Gastroenterol Clin N Am"},{"key":"37_CR14","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.287.15.1972","volume":"287","author":"N Shaheen","year":"2002","unstructured":"Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 287:1972\u20131981","journal-title":"JAMA"},{"key":"37_CR15","first-page":"745","volume":"11","author":"TL Vaughan","year":"2002","unstructured":"Vaughan TL, Kristal AR, Blount PL, et al (2002) Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett\u2019s esophagus. Cancer Epidemiol Biomarkers Prev 11:745\u2013752","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<535::AID-PATH302>3.0.CO;2-G","volume":"187","author":"CE Whittles","year":"1999","unstructured":"Whittles CE, Biddlestone LR, Burton A, et al (1999) Apoptotic and proliferative activity in the neoplastic progression of Barrett\u2019s oesophagus:a comparative study. J Pathol 187:535\u2013540","journal-title":"J Pathol"},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrc1166","volume":"3","author":"CP Wild","year":"2003","unstructured":"Wild CP, Hardie LJ (2003) Reflux, Barrett\u2019s oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676\u2013684","journal-title":"Nat Rev Cancer"},{"key":"37_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0016-5085(90)90607-3","volume":"99","author":"AJ Cameron","year":"1990","unstructured":"Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA (1990) Prevalence of columnar-lined (Barrett\u2019s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99:918\u2013922","journal-title":"Gastroenterology"},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3748\/wjg.v9.i6.1156","volume":"9","author":"LD Wang","year":"2003","unstructured":"Wang LD, Zheng S, Zheng ZY, Casson AG (2003) Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 9:1156\u20131164","journal-title":"World J Gastroenterol"},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ijc.10721","volume":"102","author":"J Powell","year":"2002","unstructured":"Powell J, McConkey CC, Gillison EW, Spychal RT (2002) Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 102:422\u2013427","journal-title":"Int J Cancer"},{"key":"37_CR21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2168.1999.01082.x","volume":"86","author":"BP Wijnhoven","year":"1999","unstructured":"Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW (1999) Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86:529\u2013535","journal-title":"Br J Surg"},{"key":"37_CR22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/ije\/30.6.1415","volume":"30","author":"DA Corley","year":"2001","unstructured":"Corley DA, Buffler PA (2001) Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 30:1415\u20131425","journal-title":"Int J Epidemiol"},{"key":"37_CR23","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (http:\/\/www.seer.cancer.gov) SEER*Stat Database:Incidence \u2013 SEER Regs Public-Use, Nov 2002 Sub (1973\u20132000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission"},{"key":"37_CR24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.pu.12.050191.002233","volume":"12","author":"TR Holford","year":"1991","unstructured":"Holford TR (1991) Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 12:425\u2013457","journal-title":"Annu Rev Public Health"},{"key":"37_CR25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0021-9681(85)90105-5","volume":"38","author":"LL Kupper","year":"1985","unstructured":"Kupper LL, Janis JM, Karmous A, Greenberg BG (1985) Statistical age\u2013period\u2013cohort analysis: a review and critique. J Chronic Dis 38:811\u2013830","journal-title":"J Chronic Dis"},{"key":"37_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00051361","volume":"3","author":"T Zheng","year":"1992","unstructured":"Zheng T, Mayne ST, Holford TR, et al (1992) Time trend and age\u2013period\u2013cohort effects on incidence of esophageal cancer in Connecticut, 1935\u201389. Cancer Causes Control 3:481\u2013492","journal-title":"Cancer Causes Control"},{"key":"37_CR27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/sim.4780060405","volume":"6","author":"D Clayton","year":"1987","unstructured":"Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: Age\u2013period and age\u2013cohort models. Stat Med 6:449\u2013467","journal-title":"Stat Med"},{"key":"37_CR28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/096228029200100306","volume":"1","author":"TR Holford","year":"1992","unstructured":"Holford TR (1992) Analysing the temporal effects of age, period and cohort. Stat Methods Med Res 1:317\u2013337","journal-title":"Stat Methods Med Res"},{"key":"37_CR29","doi-asserted-by":"crossref","first-page":"15095","DOI":"10.1073\/pnas.222118199","volume":"99","author":"EG Luebeck","year":"2002","unstructured":"Luebeck EG, Moolgavkar SH (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 99:15095\u201315100","journal-title":"Proc Natl Acad Sci USA"},{"key":"37_CR30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/0016-5085(92)91510-B","volume":"103","author":"AJ Cameron","year":"1992","unstructured":"Cameron AJ, Lomboy CT (1992) Barrett\u2019s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103:1241\u20131245","journal-title":"Gastroenterology"},{"key":"37_CR31","first-page":"8284","volume":"61","author":"DJ Wong","year":"2001","unstructured":"Wong DJ, Paulson TG, Prevo LJ, et al (2001) p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett\u2019s metaplastic epithelium. Cancer Res 61:8284\u20138289","journal-title":"Cancer Res"},{"key":"37_CR32","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-03-3249","volume":"64","author":"CC Maley","year":"2004","unstructured":"Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Reid BJ (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett\u2019s esophagus. Cancer Res 64:3414\u20133427","journal-title":"Cancer Res"},{"key":"37_CR33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1539-6924.1997.tb00878.x","volume":"17","author":"WF Heidenreich","year":"1997","unstructured":"Heidenreich WF, Luebeck EG, Moolgavkar SH (1997) Some properties of the hazard function of the two-mutation clonal expansion model. Risk Anal 17:391\u2013399","journal-title":"Risk Anal"},{"key":"37_CR34","doi-asserted-by":"crossref","first-page":"3467S","DOI":"10.1093\/jn\/132.11.3467S","volume":"132","author":"ST Mayne","year":"2002","unstructured":"Mayne ST, Navarro SA (2002) Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 132:3467S\u20133470S","journal-title":"J Nutr"},{"key":"37_CR35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0046-8177(94)90057-4","volume":"25","author":"RC Haggitt","year":"1994","unstructured":"Haggitt RC (1994) Barrett\u2019s esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25:982\u2013993","journal-title":"Hum Pathol"},{"key":"37_CR36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0016-5085(19)31680-4","volume":"75","author":"JJ Herbst","year":"1978","unstructured":"Herbst JJ, Berenson MM, McCloskey DW, Wiser WC (1978) Cell proliferation in esophageal columnar epithelium (Barrett\u2019s esophagus). Gastroenterology 75:683\u2013687","journal-title":"Gastroenterology"},{"key":"37_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/mc.10100","volume":"36","author":"P Uys","year":"2003","unstructured":"Uys P, van Helden PD (2003) On the nature of genetic changes required for the development of esophageal cancer. Mol Carcinog 36:82\u201389","journal-title":"Mol Carcinog"},{"key":"37_CR38","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1158\/0008-5472.CAN-04-1738","volume":"64","author":"CC Maley","year":"2004","unstructured":"Maley CC, Galipeau PC, Li X, et al (2004) The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 64:7629\u20137633","journal-title":"Cancer Res"},{"key":"37_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1572-0241.2002.05454.x","volume":"97","author":"AJ Cameron","year":"2002","unstructured":"Cameron AJ, Arora AS (2002) Barrett\u2019s esophagus and reflux esophagitis: is there a missing link? Am J Gastroenterol 97:273\u2013278","journal-title":"Am J Gastroenterol"},{"key":"37_CR40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1008913828105","volume":"11","author":"DC Farrow","year":"2000","unstructured":"Farrow DC, Vaughan TL, Sweeney C et al (2000) Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 11:231\u2013238","journal-title":"Cancer Causes Control"},{"key":"37_CR41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1442-2050.2002.00216.x","volume":"15","author":"AJ Cameron","year":"2002","unstructured":"Cameron AJ (2002) Epidemiology of Barrett\u2019s esophagus and adenocarcinoma. Dis Esophagus 15:106\u2013108","journal-title":"Dis Esophagus"},{"key":"37_CR42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","volume":"97","author":"H Pohl","year":"2005","unstructured":"Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142\u2013146","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"37_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.2004.041517","volume":"54","author":"J Lagergren","year":"2005","unstructured":"Lagergren J (2005) Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 54(Suppl 1):1\u20135","journal-title":"Gut"},{"key":"37_CR44","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/jnci\/djg047","volume":"95","author":"LS Engel","year":"2003","unstructured":"Engel LS, Chow W, Vaughan TL, et al (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404\u20131413","journal-title":"J Natl Cancer Inst"},{"key":"37_CR45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5694\/j.1326-5377.2003.tb05283.x","volume":"178","author":"AJ Cameron","year":"2003","unstructured":"Cameron AJ, Welborn TA, Zimmet PZ, et al (2003) Overweight and obesity in Australia:the 1999\u20132000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 178:427\u2013432","journal-title":"Med J Aust"},{"key":"37_CR46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ijc.10697","volume":"102","author":"C La Vecchia","year":"2002","unstructured":"La Vecchia C, Negri E, Lagiou P, Trichopoulos D (2002) Oesophageal adenocarcinoma: a paradigm of mechanical carcinogenesis? Int J Cancer 102:269\u2013270","journal-title":"Int J Cancer"},{"key":"37_CR47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/8816","volume":"22","author":"MT Barrett","year":"1999","unstructured":"Barrett MT, Sanchez CA, Prevo LJ, et al (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22:106\u2013109","journal-title":"Nat Genet"},{"key":"37_CR48","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-03-3249","volume":"64","author":"CC Maley","year":"2004","unstructured":"Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Reid BJ (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett\u2019s esophagus. Cancer Res 64:3414\u20133427","journal-title":"Cancer Res"},{"key":"37_CR49","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/gut.2003.033837","volume":"53","author":"NJ Shaheen","year":"2004","unstructured":"Shaheen NJ, Inadomi JM, Overholt BF, Sharma P (2004) What is the best management strategy for high grade dysplasia in Barrett\u2019s oesophagus? A cost effectiveness analysis. Gut 53:1736\u20131744","journal-title":"Gut"},{"issue":"Suppl 1","key":"37_CR50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0953-0673.2004.01838.x","volume":"19","author":"SJ Spechler","year":"2004","unstructured":"Spechler SJ, Barr H (2004) Review article: screening and surveillance of Barrett\u2019s oesophagus: what is a cost-effective framework? Aliment Pharmacol Ther 19(Suppl 1):49\u201353","journal-title":"Aliment Pharmacol Ther"},{"key":"37_CR51","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","volume":"6","author":"TL Vaughan","year":"2005","unstructured":"Vaughan TL, Dong LM, Blount PL, et al (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett\u2019s oesophagus: a prospective study. Lancet Oncol 6:945\u2013952","journal-title":"Lancet Oncol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-006-0037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-006-0037-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-006-0037-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T17:52:28Z","timestamp":1627581148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-006-0037-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s10552-006-0037-3","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}